M.I.TECH Co.Ltd (179290) - Cash Flow Conversion Efficiency
Based on the latest financial reports, M.I.TECH Co.Ltd (179290) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.62 Billion ≈ $3.81 Million USD) by net assets (₩120.80 Billion ≈ $81.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 179290 stock market capitalisation for the company's overall valuation and market capitalisation.
M.I.TECH Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how M.I.TECH Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
M.I.TECH Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of M.I.TECH Co.Ltd ranked by their cash flow conversion efficiency. Explore M.I.TECH Co.Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Darya-Varia Laboratoria Tbk
JK:DVLA
|
0.063x |
|
Binh Dien Fertilizer JSC
VN:BFC
|
0.226x |
|
Dimerix Ltd
AU:DXB
|
3.087x |
|
Baby Bunting Group Ltd
AU:BBN
|
0.306x |
|
Velo3D, Inc.
NASDAQ:VELO
|
-0.200x |
|
Kumho Petro Chemical Co Ltd
KO:011785
|
0.013x |
|
Hsinli Chemical Industrial
TWO:4303
|
0.015x |
|
Cellectis
PA:ALCLS
|
-0.255x |
Annual Cash Flow Conversion Efficiency for M.I.TECH Co.Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of M.I.TECH Co.Ltd from 2015 to 2024. View today's stock price for M.I.TECH Co.Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩108.83 Billion ≈ $73.75 Million |
₩23.66 Billion ≈ $16.04 Million |
0.217x | +13.48% |
| 2023-12-31 | ₩92.94 Billion ≈ $62.98 Million |
₩17.81 Billion ≈ $12.07 Million |
0.192x | +86.33% |
| 2022-12-31 | ₩83.55 Billion ≈ $56.62 Million |
₩8.59 Billion ≈ $5.82 Million |
0.103x | -59.70% |
| 2021-12-31 | ₩64.76 Billion ≈ $43.89 Million |
₩16.52 Billion ≈ $11.20 Million |
0.255x | +262.09% |
| 2020-12-31 | ₩55.40 Billion ≈ $37.55 Million |
₩3.90 Billion ≈ $2.65 Million |
0.070x | +9.45% |
| 2019-12-31 | ₩48.25 Billion ≈ $32.70 Million |
₩3.11 Billion ≈ $2.11 Million |
0.064x | +41.35% |
| 2018-12-31 | ₩44.77 Billion ≈ $30.34 Million |
₩2.04 Billion ≈ $1.38 Million |
0.046x | -11.71% |
| 2017-12-31 | ₩18.67 Billion ≈ $12.66 Million |
₩963.43 Million ≈ $652.90K |
0.052x | -69.14% |
| 2016-12-31 | ₩16.63 Billion ≈ $11.27 Million |
₩2.78 Billion ≈ $1.88 Million |
0.167x | +462.76% |
| 2015-12-31 | ₩14.71 Billion ≈ $9.97 Million |
₩-677.68 Million ≈ $-459.25K |
-0.046x | -- |
About M.I.TECH Co.Ltd
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more